Monday, February 10, 2025

Fib-4 Index Highlights Atherosclerosis Risk in Type 2 Diabetics

Similar articles

A recent study has uncovered a significant link between elevated Fibrosis-4 (Fib-4) index levels and carotid atherosclerosis (CA) in individuals with type 2 diabetes. This extensive research, involving over two and a half thousand diabetic patients, highlights the potential of Fib-4 as a valuable biomarker for cardiovascular complications in this population.

Table of Contents

Subscribe Weekly Market Access News

* indicates required

Comprehensive Study Design

The investigation screened 2,658 hospitalized patients diagnosed with type 2 diabetes, categorizing them into three groups based on their Fib-4 scores: below 1.3, between 1.3 and 2.67, and above 2.67. Utilizing logistic regression analysis, the study examined the relationship between Fib-4 levels and the presence of CA, while accounting for variables such as gender, age, body mass index (BMI), hypertension, smoking, and alcohol consumption. Additionally, Receiver Operating Characteristic (ROC) curve analysis was employed to assess the predictive accuracy of Fib-4 for CA, increased carotid intima-media thickness (CIMT), and carotid plaques.

Significant Correlations and Outcomes

Results indicated that 65.3% of participants exhibited carotid atherosclerosis, with nearly half presenting increased CIMT or carotid plaques. The prevalence of CA consistently rose across the Fib-4 groups, showing statistically significant differences. Notably, individuals with Fib-4 scores exceeding 2.67 demonstrated a higher incidence of increased CIMT and carotid plaques compared to those with lower Fib-4 levels. The ROC analysis revealed moderate predictive power of Fib-4 for CA, suggesting its potential utility in clinical assessments.

– Higher Fib-4 levels may indicate increased risk of carotid atherosclerosis in diabetic patients.
– Fib-4 could serve as an accessible marker for early detection of cardiovascular issues in type 2 diabetes.
– Gender, age, and BMI influence the strength of the association between Fib-4 and CA.

Integrating Fib-4 index evaluations into routine screenings for type 2 diabetes patients could enhance early identification of those at elevated risk for carotid atherosclerosis. This proactive approach allows healthcare providers to implement timely interventions, potentially reducing the incidence of severe cardiovascular complications. The study also emphasizes the need for larger-scale and multicenter research to validate Fib-4’s role as a reliable biomarker across diverse populations.

Monitoring Fib-4 levels presents a promising strategy for improving cardiovascular risk assessment in type 2 diabetes management. As evidence grows supporting the connection between liver fibrosis scores and cardiovascular health, incorporating such biomarkers into clinical practice may lead to more personalized and effective treatment plans. Ultimately, this could enhance patient outcomes and lower the burden of cardiovascular diseases among those with type 2 diabetes.

Source


This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Latest article